C J Bailey|P R Flatt - JoVE Visualize

Showing results (171-180 of 375) with videos related to

Pageof 38

Sort By:

Medical Microbiology and Immunology|January 1, 1992

Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigenB Fleischer, C J Bailey

British Journal of Pharmacology|January 8, 1998

Glucose-lowering effect of BTS 67 582T Page, C J Bailey

Diabetes, Obesity & Metabolism|June 23, 2015

Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetesN Irwin, V Pathak, N M Pathak, et al.

Diabetes, Obesity & Metabolism|March 23, 2011

Dual modulation of GIP and glucagon action by the low molecular weight compound 4-hydroxybenzoic acid 2-bromobenzylidene hydrazideZ J Franklin, B McDonnell, I A Montgomery, et al.

Biochemical Pharmacology|March 17, 1992

Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activityC R Barnett, J Wilson, C R Wolf, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 25, 2010

Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat dietY H A Abdel-Wahab, S Patterson, P R Flatt, et al.

Biochimica Et Biophysica Acta|October 31, 1998

Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cellsF P O'Harte, Y H Abdel-Wahab, J M Conlon, et al.

Peptides|January 1, 1997

Effects of non-glycated and glycated glucagon-like peptide-1(7-36) amide on glucose metabolism in isolated mouse abdominal muscleF P O'Harte, A M Gray, Y H Abdel-Wahab, et al.

Diabetologia|October 30, 1998

Glycation of glucagon-like peptide-1(7-36)amide: characterization and impaired action on rat insulin secreting cellsF P O'Harte, Y H Abdel-Wahab, J M Conlon, et al.

Diabetologia|February 1, 1989

Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated ratsP R Flatt, S L Bass, A D Ayrton, et al.

Pageof 38

Showing results (171-180 of 375) with videos related to

Sort By:

Pageof 38

Medical Microbiology and Immunology|January 1, 1992

Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigenB Fleischer, C J Bailey

British Journal of Pharmacology|January 8, 1998

Glucose-lowering effect of BTS 67 582T Page, C J Bailey

Diabetes, Obesity & Metabolism|June 23, 2015

Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetesN Irwin, V Pathak, N M Pathak, et al.

Diabetes, Obesity & Metabolism|March 23, 2011

Dual modulation of GIP and glucagon action by the low molecular weight compound 4-hydroxybenzoic acid 2-bromobenzylidene hydrazideZ J Franklin, B McDonnell, I A Montgomery, et al.

Biochemical Pharmacology|March 17, 1992

Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activityC R Barnett, J Wilson, C R Wolf, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 25, 2010

Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat dietY H A Abdel-Wahab, S Patterson, P R Flatt, et al.

Biochimica Et Biophysica Acta|October 31, 1998

Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cellsF P O'Harte, Y H Abdel-Wahab, J M Conlon, et al.

Peptides|January 1, 1997

Effects of non-glycated and glycated glucagon-like peptide-1(7-36) amide on glucose metabolism in isolated mouse abdominal muscleF P O'Harte, A M Gray, Y H Abdel-Wahab, et al.

Diabetologia|October 30, 1998

Glycation of glucagon-like peptide-1(7-36)amide: characterization and impaired action on rat insulin secreting cellsF P O'Harte, Y H Abdel-Wahab, J M Conlon, et al.

Diabetologia|February 1, 1989

Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated ratsP R Flatt, S L Bass, A D Ayrton, et al.

Pageof 38